US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OS Therapies

1.58

-0.0200-1.25%

Volume:70.83K

Turnover:111.88K

Market Cap:73.42M

PE:-1.50

High:1.63

Open:1.63

Low:1.56

Close:1.60

52wk High:2.25

52wk Low:1.15

Shares:46.47M

Float Shares:33.71M

Volume Ratio:0.55

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0524

EPS(LYR):-0.9829

ROE:-914.04%

ROA:-232.65%

PB:-6.16

PE(LYR):-1.61

Loading ...

Overview Company News Filings

OS Therapies Names Kerry Clem Chief Commercial Officer

OS Therapies: Regulatory Momentum for Herlystic Supports Continued Buy Rating with Unchanged $6 Price Target

OS Therapies Targets Mid-Q4 2026 Start for UK Phase 3 OST-HER2 Trial in Metastatic Osteosarcoma

Analysts Offer Insights on NA Companies: Waystar Holding Corp. (WAY) and OS Therapies Incorporated (OSTX)

OS Therapies announces full alignment on UK authorization application

OS Therapies Announces Prospectus for Secondary Share Resales

OS Therapies Files Prospectus for Resale of up to 5,874,094 Shares by Selling Stockholders

OS Therapies Stockholders Approve Incentive Plan and Board

OS Therapies Shareholders Approve Amended 2023 Incentive Compensation Plan at Annual Meeting

Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and SailPoint, Inc. (SAIL)

Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and Concentra Group Holdings Parent, Inc. (CON)

OS Therapies Reports 71.2% 3-Year Survival in Phase 2b OST-HER2 Metastatic Osteosarcoma Trial

OS Therapies Management to Attend H.C. Wainwright Global Investment Conference

OS Therapies Launches $75 Million At-The-Market Offering

OS Therapies Launches USD 75 Million At-the-Market Equity Offering Via Jefferies

Os Therapies - Enters Open Market Sale Agreement with Jefferies - SEC Filing

THOMSON REUTERS

Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and Nicola Mining Inc. Unsponsored ADR (NICM)

OS Therapies Net Loss Widens to $19.03 Million in FY26 First Half; Revenue Remains no Revenue

OS Therapies Wins FDA Type C Meeting to Review 2.5-Year Survival Data for OST-HER2 Phase 2b Osteosarcoma Trial

OS Therapies Announces Convertible Note Financing and Warrants

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/OSTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OSTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSTX\",,,,,undefined,":{"symbol":"OSTX","market":"US","secType":"STK","nameCN":"OS Therapies","latestPrice":1.58,"timestamp":1790869269514,"preClose":1.6,"halted":0,"volume":70825,"delay":0,"changeRate":-0.012500000000000011,"floatShares":33708100,"shares":46470790,"eps":-1.05241,"marketStatus":"Trading","change":-0.02,"latestTime":"10-01 11:41:55 EDT","open":1.63,"high":1.63,"low":1.56,"amount":111878.923725,"amplitude":0.04375,"askPrice":1.59,"askSize":124,"bidPrice":1.58,"bidSize":303,"shortable":3,"etf":0,"ttmEps":-1.05241,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"listingDate":1719460800000,"exchange":"AMEX","adjPreClose":1.6,"preHourTrading":{"tag":"盘前","latestPrice":1.6297,"preClose":1.6,"latestTime":"09:07 EDT","volume":203,"amount":325.0074863,"timestamp":1790860072511,"change":0.0297,"changeRate":0.018562,"amplitude":0.06875},"postHourTrading":{"tag":"盘后","latestPrice":1.6,"preClose":1.6,"latestTime":"19:30 EDT","volume":638,"amount":1021.6132,"timestamp":1790811001926,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.55148},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSTX\",,,,,undefined,":{"symbol":"OSTX","floatShares":33708100,"roa":"-232.65%","roe":"-914.04%","lyrEps":-0.982926,"volumeRatio":0.55148,"shares":46470790,"dividePrice":0,"high":1.63,"amplitude":0.04375,"preClose":1.6,"low":1.56,"week52Low":1.15,"pbRate":"-6.16","week52High":2.25,"institutionHeld":0,"latestPrice":1.58,"committee":0.419204,"eps":-1.05241,"divideRate":0,"volume":70825,"delay":0,"ttmEps":-1.05241,"open":1.63,"prevYearClose":1.4,"prevWeekClose":1.66,"prevMonthClose":1.6,"prevQuarterClose":1.6,"fiveDayClose":1.66,"twentyDayClose":1.71,"sixtyDayClose":1.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSTX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OSTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1783656000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OSTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OSTX","date":"2026-09-30","current":-1.506067,"percent":0.974312,"low":-14.897496,"twenty":-7.217779,"median":-4.33237,"eighty":-2.38307,"high":-1.629046,"avg":-5.048999,"sd":3.232317,"marketCap":74262578},"quantilePoints":[{"date":"2024-06-14","current":-13.217965,"twenty":-13.216533,"median":-13.214385,"eighty":-13.212238,"marketCap":102988885},{"date":"2024-06-21","current":-10.574372,"twenty":-13.217965,"median":-13.214385,"eighty":-12.156232,"marketCap":82391108},{"date":"2024-06-28","current":-13.217965,"twenty":-13.217965,"median":-13.217965,"eighty":-13.210806,"marketCap":102988885},{"date":"2024-08-02","current":-6.458845,"twenty":-13.217965,"median":-13.217965,"eighty":-11.101659,"marketCap":50324634},{"date":"2024-08-09","current":-8.117559,"twenty":-13.217965,"median":-10.433676,"eighty":-8.215548,"marketCap":63248641},{"date":"2024-08-16","current":-10.993719,"twenty":-13.216533,"median":-10.29298,"eighty":-8.15204,"marketCap":70975778},{"date":"2024-08-23","current":-13.004275,"twenty":-13.182439,"median":-10.833368,"eighty":-8.309008,"marketCap":83955991},{"date":"2024-08-30","current":-11.710317,"twenty":-13.188909,"median":-11.710317,"eighty":-8.610078,"marketCap":75602161},{"date":"2024-09-06","current":-12.939577,"twenty":-13.217965,"median":-12.391225,"eighty":-8.620371,"marketCap":83538300},{"date":"2024-09-13","current":-11.32213,"twenty":-13.217965,"median":-12.261039,"eighty":-9.289415,"marketCap":73096012},{"date":"2024-09-20","current":-11.483875,"twenty":-13.217965,"median":-11.710317,"eighty":-10.29298,"marketCap":74140241},{"date":"2024-09-27","current":-9.575287,"twenty":-13.210806,"median":-11.435351,"eighty":-9.575287,"marketCap":61818342},{"date":"2024-10-04","current":-9.727327,"twenty":-13.101322,"median":-11.354479,"eighty":-9.316172,"marketCap":62799917},{"date":"2024-10-11","current":-9.931126,"twenty":-13.068973,"median":-11.192735,"eighty":-9.413543,"marketCap":64115645},{"date":"2024-10-18","current":-9.769381,"twenty":-13.068973,"median":-10.859351,"eighty":-9.542938,"marketCap":63071416},{"date":"2024-10-25","current":-9.413543,"twenty":-13.004275,"median":-10.610453,"eighty":-9.542938,"marketCap":60774113},{"date":"2024-10-31","current":-8.782738,"twenty":-12.952517,"median":-10.592413,"eighty":-9.394069,"marketCap":56701621},{"date":"2024-11-08","current":-9.085848,"twenty":-12.836061,"median":-10.29298,"eighty":-9.218608,"marketCap":58658505},{"date":"2024-11-15","current":-7.116768,"twenty":-12.603148,"median":-10.141393,"eighty":-8.950952,"marketCap":45946065},{"date":"2024-11-22","current":-5.272053,"twenty":-12.423258,"median":-9.769381,"eighty":-8.605027,"marketCap":38782655},{"date":"2024-11-29","current":-6.178419,"twenty":-12.235002,"median":-9.759676,"eighty":-8.507772,"marketCap":45450128},{"date":"2024-12-06","current":-5.370028,"twenty":-11.917351,"median":-9.716005,"eighty":-8.143742,"marketCap":39503383},{"date":"2024-12-13","current":-12.876517,"twenty":-11.917351,"median":-9.704683,"eighty":-7.804035,"marketCap":94723165},{"date":"2024-12-20","current":-11.288606,"twenty":-11.937313,"median":-9.73218,"eighty":-8.125896,"marketCap":83042057},{"date":"2024-12-27","current":-14.738704,"twenty":-12.001827,"median":-9.761941,"eighty":-8.139646,"marketCap":108421919},{"date":"2025-01-03","current":-12.068126,"twenty":-12.384347,"median":-9.850254,"eighty":-8.168424,"marketCap":88776420},{"date":"2025-01-10","current":-14.782011,"twenty":-12.810182,"median":-10.086184,"eighty":-8.234384,"marketCap":108740495},{"date":"2025-01-17","current":-11.8949,"twenty":-12.876517,"median":-10.189917,"eighty":-8.475423,"marketCap":87502117},{"date":"2025-01-24","current":-8.430366,"twenty":-12.823449,"median":-10.125219,"eighty":-8.466412,"marketCap":62016063},{"date":"2025-01-31","current":-5.629868,"twenty":-12.632281,"median":-9.850254,"eighty":-8.128675,"marketCap":41414837},{"date":"2025-02-07","current":-5.600996,"twenty":-12.558673,"median":-9.759676,"eighty":-7.471942,"marketCap":41202453},{"date":"2025-02-14","current":-5.745352,"twenty":-12.423258,"median":-9.716005,"eighty":-6.985183,"marketCap":42264372},{"date":"2025-02-21","current":-5.456641,"twenty":-12.370592,"median":-9.688508,"eighty":-6.36129,"marketCap":40140534},{"date":"2025-02-28","current":-4.734863,"twenty":-12.322192,"median":-9.575287,"eighty":-6.039722,"marketCap":34830939},{"date":"2025-03-07","current":-4.850347,"twenty":-12.19815,"median":-9.413543,"eighty":-5.818713,"marketCap":35680475},{"date":"2025-03-14","current":-4.619378,"twenty":-12.093217,"median":-9.316172,"eighty":-5.658739,"marketCap":33981404},{"date":"2025-03-21","current":-4.590507,"twenty":-12.033481,"median":-9.267973,"eighty":-5.589448,"marketCap":33769021},{"date":"2025-03-28","current":-4.677121,"twenty":-11.941094,"median":-9.085848,"eighty":-5.445093,"marketCap":34406172},{"date":"2025-04-04","current":-3.682014,"twenty":-11.842932,"median":-9.000397,"eighty":-5.346931,"marketCap":32707102},{"date":"2025-04-11","current":-2.731469,"twenty":-11.788323,"median":-8.747948,"eighty":-5.012916,"marketCap":24263468},{"date":"2025-04-17","current":-3.828934,"twenty":-11.749136,"median":-8.669517,"eighty":-4.901959,"marketCap":34012183},{"date":"2025-04-25","current":-3.926486,"twenty":-11.61974,"median":-8.601309,"eighty":-4.833024,"marketCap":34878735},{"date":"2025-05-02","current":-4.706906,"twenty":-11.475058,"median":-8.516979,"eighty":-4.792605,"marketCap":41811155},{"date":"2025-05-09","current":-4.804459,"twenty":-11.45771,"median":-8.491597,"eighty":-4.792605,"marketCap":42677707},{"date":"2025-05-16","current":-4.048427,"twenty":-11.438586,"median":-8.234384,"eighty":-4.718089,"marketCap":35961926},{"date":"2025-05-23","current":-2.933033,"twenty":-11.406237,"median":-8.124506,"eighty":-4.677121,"marketCap":33145630},{"date":"2025-05-30","current":-3.928425,"twenty":-11.380358,"median":-7.63641,"eighty":-4.64825,"marketCap":44394361},{"date":"2025-06-06","current":-4.052742,"twenty":-11.348009,"median":-7.333748,"eighty":-4.596281,"marketCap":45799246},{"date":"2025-06-13","current":-4.574874,"twenty":-11.315425,"median":-7.167274,"eighty":-4.590507,"marketCap":51699762},{"date":"2025-06-20","current":-4.525147,"twenty":-11.288606,"median":-6.448552,"eighty":-4.525147,"marketCap":51137808},{"date":"2025-06-27","current":-4.500284,"twenty":-11.257432,"median":-6.245836,"eighty":-4.450557,"marketCap":50856831},{"date":"2025-07-03","current":-4.804944,"twenty":-11.153916,"median":-6.178419,"eighty":-4.480042,"marketCap":54299732},{"date":"2025-07-11","current":-4.384839,"twenty":-11.071717,"median":-6.001438,"eighty":-4.444649,"marketCap":49552214},{"date":"2025-07-18","current":-4.411096,"twenty":-11.057637,"median":-5.848373,"eighty":-4.413618,"marketCap":49848934},{"date":"2025-07-25","current":-5.118748,"twenty":-11.006503,"median":-5.726085,"eighty":-4.413618,"marketCap":57845975},{"date":"2025-08-01","current":-5.266689,"twenty":-10.886225,"median":-5.658739,"eighty":-4.423405,"marketCap":59517824},{"date":"2025-08-08","current":-5.177924,"twenty":-10.817778,"median":-5.632611,"eighty":-4.43502,"marketCap":58514715},{"date":"2025-08-15","current":-6.36145,"twenty":-10.649839,"median":-5.600996,"eighty":-4.43838,"marketCap":71889507},{"date":"2025-08-22","current":-5.360009,"twenty":-10.610453,"median":-5.567348,"eighty":-4.444649,"marketCap":76540639},{"date":"2025-08-29","current":-5.047341,"twenty":-10.610453,"median":-5.538676,"eighty":-4.449676,"marketCap":72075768},{"date":"2025-09-05","current":-4.667674,"twenty":-10.601601,"median":-5.456641,"eighty":-4.458388,"marketCap":66654139},{"date":"2025-09-12","current":-5.119065,"twenty":-10.582903,"median":-5.4212,"eighty":-4.477891,"marketCap":73099984},{"date":"2025-09-19","current":-4.897461,"twenty":-10.460155,"median":-5.370028,"eighty":-4.495136,"marketCap":69935483},{"date":"2025-09-26","current":-4.675856,"twenty":-10.329392,"median":-5.362697,"eighty":-4.515202,"marketCap":66770981},{"date":"2025-10-03","current":-4.409931,"twenty":-10.231142,"median":-5.325865,"eighty":-4.459866,"marketCap":62973579},{"date":"2025-10-10","current":-4.520733,"twenty":-10.170508,"median":-5.292169,"eighty":-4.471291,"marketCap":64555830},{"date":"2025-10-17","current":-4.099684,"twenty":-10.138159,"median":-5.266689,"eighty":-4.443146,"marketCap":58543277},{"date":"2025-10-24","current":-4.250282,"twenty":-10.078376,"median":-5.177924,"eighty":-4.421116,"marketCap":60693806},{"date":"2025-10-31","current":-4.156353,"twenty":-9.977535,"median":-5.177924,"eighty":-4.412988,"marketCap":59352507},{"date":"2025-11-07","current":-4.273765,"twenty":-9.834079,"median":-5.118748,"eighty":-4.402429,"marketCap":61029131},{"date":"2025-11-14","current":-4.273765,"twenty":-9.766275,"median":-5.104544,"eighty":-4.391176,"marketCap":61029131},{"date":"2025-11-21","current":-2.971008,"twenty":-9.761488,"median":-5.059977,"eighty":-4.38129,"marketCap":54322633},{"date":"2025-11-28","current":-3.447432,"twenty":-9.750618,"median":-5.0362,"eighty":-4.358965,"marketCap":63033690},{"date":"2025-12-05","current":-3.50521,"twenty":-9.73315,"median":-4.994703,"eighty":-4.321289,"marketCap":64090120},{"date":"2025-12-12","current":-3.909657,"twenty":-9.718269,"median":-4.969558,"eighty":-4.300776,"marketCap":71485134},{"date":"2025-12-19","current":-3.081503,"twenty":-9.704683,"median":-4.950787,"eighty":-4.273765,"marketCap":56342963},{"date":"2025-12-26","current":-2.927428,"twenty":-9.698213,"median":-4.936226,"eighty":-4.231496,"marketCap":53525815},{"date":"2026-01-02","current":-2.696315,"twenty":-9.672334,"median":-4.919621,"eighty":-4.226786,"marketCap":49300092},{"date":"2026-01-09","current":-2.965947,"twenty":-9.672334,"median":-4.910716,"eighty":-4.157441,"marketCap":54230102},{"date":"2026-01-16","current":-2.811872,"twenty":-9.575287,"median":-4.897871,"eighty":-4.145979,"marketCap":51412953},{"date":"2026-01-23","current":-2.831131,"twenty":-9.549408,"median":-4.897461,"eighty":-4.087363,"marketCap":51765097},{"date":"2026-01-30","current":-2.657797,"twenty":-9.439422,"median":-4.891008,"eighty":-3.973179,"marketCap":48595805},{"date":"2026-02-06","current":-2.445943,"twenty":-9.413543,"median":-4.875301,"eighty":-3.908145,"marketCap":44722227},{"date":"2026-02-13","current":-2.23409,"twenty":-9.413543,"median":-4.874269,"eighty":-3.823969,"marketCap":40848648},{"date":"2026-02-20","current":-2.311128,"twenty":-9.35512,"median":-4.850347,"eighty":-3.774842,"marketCap":42257222},{"date":"2026-02-27","current":-2.754094,"twenty":-9.300118,"median":-4.8312,"eighty":-3.691488,"marketCap":50356523},{"date":"2026-03-06","current":-2.908169,"twenty":-9.286254,"median":-4.804944,"eighty":-3.509217,"marketCap":53173671},{"date":"2026-03-13","current":-2.927428,"twenty":-9.264738,"median":-4.804459,"eighty":-3.458987,"marketCap":53525815},{"date":"2026-03-20","current":-2.888909,"twenty":-9.232389,"median":-4.792605,"eighty":-3.347283,"marketCap":52821528},{"date":"2026-03-27","current":-2.638537,"twenty":-9.139288,"median":-4.763734,"eighty":-3.283217,"marketCap":48243662},{"date":"2026-04-02","current":-1.869843,"twenty":-9.07459,"median":-4.734863,"eighty":-3.19573,"marketCap":53765188},{"date":"2026-04-10","current":-1.973708,"twenty":-9.037738,"median":-4.706449,"eighty":-3.15544,"marketCap":56751705},{"date":"2026-04-17","current":-2.046809,"twenty":-9.001875,"median":-4.699192,"eighty":-3.081503,"marketCap":58853620},{"date":"2026-04-24","current":-2.119909,"twenty":-8.908899,"median":-4.683564,"eighty":-3.034837,"marketCap":60955535},{"date":"2026-05-01","current":-2.485411,"twenty":-8.768822,"median":-4.677121,"eighty":-2.985206,"marketCap":71465110},{"date":"2026-05-08","current":-2.485411,"twenty":-8.7364,"median":-4.657962,"eighty":-2.965947,"marketCap":71465110},{"date":"2026-05-15","current":-2.748572,"twenty":-8.699253,"median":-4.619378,"eighty":-2.954392,"marketCap":79032004},{"date":"2026-05-22","current":-2.169023,"twenty":-8.649859,"median":-4.610947,"eighty":-2.927428,"marketCap":76509706},{"date":"2026-05-29","current":-2.500026,"twenty":-8.617798,"median":-4.590507,"eighty":-2.912021,"marketCap":88185449},{"date":"2026-06-05","current":-2.335883,"twenty":-8.605027,"median":-4.574874,"eighty":-2.888909,"marketCap":82395496},{"date":"2026-06-12","current":-2.159113,"twenty":-8.590585,"median":-4.542637,"eighty":-2.850391,"marketCap":76160161},{"date":"2026-06-18","current":-2.17174,"twenty":-8.57247,"median":-4.525147,"eighty":-2.831131,"marketCap":76605542},{"date":"2026-06-26","current":-2.272751,"twenty":-8.516979,"median":-4.520733,"eighty":-2.811872,"marketCap":80168590},{"date":"2026-07-02","current":-2.285377,"twenty":-8.509613,"median":-4.508587,"eighty":-2.790024,"marketCap":80613971},{"date":"2026-07-10","current":-2.17174,"twenty":-8.507772,"median":-4.481912,"eighty":-2.769501,"marketCap":76605542},{"date":"2026-07-17","current":-1.893959,"twenty":-8.481893,"median":-4.461622,"eighty":-2.745824,"marketCap":66807159},{"date":"2026-07-24","current":-1.969717,"twenty":-8.439377,"median":-4.448354,"eighty":-2.715575,"marketCap":69479445},{"date":"2026-07-31","current":-1.969717,"twenty":-8.312777,"median":-4.438389,"eighty":-2.696315,"marketCap":69479445},{"date":"2026-08-07","current":-2.058102,"twenty":-8.184914,"median":-4.437352,"eighty":-2.657797,"marketCap":72597112},{"date":"2026-08-14","current":-2.020223,"twenty":-8.139646,"median":-4.419971,"eighty":-2.618363,"marketCap":71260969},{"date":"2026-08-21","current":-1.787426,"twenty":-8.123117,"median":-4.411096,"eighty":-2.573055,"marketCap":70370207},{"date":"2026-08-28","current":-1.968306,"twenty":-7.906822,"median":-4.400554,"eighty":-2.529271,"marketCap":77491386},{"date":"2026-09-04","current":-2.132332,"twenty":-7.610426,"median":-4.389861,"eighty":-2.500031,"marketCap":83949001},{"date":"2026-09-11","current":-2.132332,"twenty":-7.50649,"median":-4.384839,"eighty":-2.485411,"marketCap":83949001},{"date":"2026-09-18","current":-2.144048,"twenty":-7.437393,"median":-4.363615,"eighty":-2.42693,"marketCap":84410259},{"date":"2026-09-25","current":-1.944874,"twenty":-7.28736,"median":-4.344211,"eighty":-2.386388,"marketCap":76568869},{"date":"2026-09-30","current":-1.886293,"twenty":-7.217779,"median":-4.33237,"eighty":-2.38307,"marketCap":74262578}],"updateTime":1790869315056},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672522677","title":"OS Therapies Names Kerry Clem Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672522677","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672522677?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:33","pubTimestamp":1790857995,"startTime":"0","endTime":"0","summary":"OS Therapies names Kerry Clem chief commercial officerOS Therapies appointed Kerry Clem as chief commercial officer to lead U.S., U.K., and European launch planning for Herlystic.Clem previously serve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL2CRFtR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670425053","title":"OS Therapies: Regulatory Momentum for Herlystic Supports Continued Buy Rating with Unchanged $6 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2670425053","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670425053?lang=en_us&edition=fundamental","pubTime":"2026-09-25 23:55","pubTimestamp":1790351728,"startTime":"0","endTime":"0","summary":"Analyst Jason McCarthy of Maxim Group maintained a Buy rating on OS Therapies Incorporated, retaining the price target of $6.00. Jason McCarthy has...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/os-therapies-regulatory-momentum-for-herlystic-supports-continued-buy-rating-with-unchanged-6-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/os-therapies-regulatory-momentum-for-herlystic-supports-continued-buy-rating-with-unchanged-6-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669579361","title":"OS Therapies Targets Mid-Q4 2026 Start for UK Phase 3 OST-HER2 Trial in Metastatic Osteosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2669579361","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669579361?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:31","pubTimestamp":1789986690,"startTime":"0","endTime":"0","summary":"OS Therapies targets mid-Q4 2026 start for UK Phase 3 OST-HER2 trial in metastatic osteosarcomaOS Therapies outlined plans to seek early market access for OST-HER2 in metastatic osteosarcoma via a U.K","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL2HHHhm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462325","title":"Analysts Offer Insights on NA Companies: Waystar Holding Corp. (WAY) and OS Therapies Incorporated (OSTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462325","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462325?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:00","pubTimestamp":1789484426,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Waystar Holding Corp. (WAY) and OS Therapies Incorporated (O...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-waystar-holding-corp-way-and-os-therapies-incorporated-ostx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-waystar-holding-corp-way-and-os-therapies-incorporated-ostx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0757428866.USD","BK4139","LU1815336091.USD","BK4167","LU1169589451.USD","NA","WAY","OSTX","BK4141","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667162841","title":"OS Therapies announces full alignment on UK authorization application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667162841","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667162841?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:10","pubTimestamp":1789481410,"startTime":"0","endTime":"0","summary":"OS Therapies (OSTX) announced that it has achieved full alignment with the U.K. Medicines and Healthcare products Regulatory Agency on its pending ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-announces-full-alignment-on-uk-authorization-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-announces-full-alignment-on-uk-authorization-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LABU","BK4588","BK4585","OSTX","BK4581","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666519894","title":"OS Therapies Announces Prospectus for Secondary Share Resales","url":"https://stock-news.laohu8.com/highlight/detail?id=2666519894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666519894?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:47","pubTimestamp":1789076874,"startTime":"0","endTime":"0","summary":"An update from OS Therapies Incorporated ( ($OSTX) ) is now available. On September 10, 2026, OS Therapies Incorporated filed a prospectus suppleme...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/os-therapies-announces-prospectus-for-secondary-share-resales?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/os-therapies-announces-prospectus-for-secondary-share-resales?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666951621","title":"OS Therapies Files Prospectus for Resale of up to 5,874,094 Shares by Selling Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2666951621","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666951621?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:28","pubTimestamp":1789075724,"startTime":"0","endTime":"0","summary":"OS Therapies files prospectus for resale of up to 5,874,094 shares by selling stockholdersOS Therapies filed a prospectus supplement for the resale of up to 5,874,094 common shares by selling stockholders.The filing forms part of an existing shelf registration statement on Form S-3.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbmDQ77:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666558942","title":"OS Therapies Stockholders Approve Incentive Plan and Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2666558942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666558942?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:26","pubTimestamp":1788989212,"startTime":"0","endTime":"0","summary":"OS Therapies Incorporated ( ($OSTX) ) has provided an announcement. On September 9, 2026, OS Therapies Incorporated stockholders approved an amendm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/os-therapies-stockholders-approve-incentive-plan-and-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/os-therapies-stockholders-approve-incentive-plan-and-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530830","title":"OS Therapies Shareholders Approve Amended 2023 Incentive Compensation Plan at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530830","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530830?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:18","pubTimestamp":1788985093,"startTime":"0","endTime":"0","summary":"OS Therapies shareholders approve amended 2023 incentive compensation plan at annual meetingOS Therapies held its annual shareholder meeting on Sept. 9, 2026.Shareholders approved an amended and resta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL25Wr7s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666253758","title":"Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and SailPoint, Inc. (SAIL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666253758","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666253758?lang=en_us&edition=fundamental","pubTime":"2026-09-10 03:00","pubTimestamp":1788980419,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on OS Therapies Incorporated (OSTX) and SailPoint, Inc. (SAIL) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-os-therapies-incorporated-ostx-and-sailpoint-inc-sail-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-os-therapies-incorporated-ostx-and-sailpoint-inc-sail-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NA","BK4141","BK4023","BK4097","SAIL","OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665379226","title":"Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and Concentra Group Holdings Parent, Inc. (CON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665379226","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665379226?lang=en_us&edition=fundamental","pubTime":"2026-09-08 23:40","pubTimestamp":1788882011,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on OS Therapies Incorporated (OSTX) and Concentra Group Holding...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-os-therapies-incorporated-ostx-and-concentra-group-holdings-parent-inc-con-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-os-therapies-incorporated-ostx-and-concentra-group-holdings-parent-inc-con-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CON","BK4185","NA","OSTX","BK4139","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665232131","title":"OS Therapies Reports 71.2% 3-Year Survival in Phase 2b OST-HER2 Metastatic Osteosarcoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232131","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665232131?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:02","pubTimestamp":1788861755,"startTime":"0","endTime":"0","summary":"OS Therapies reports 71.2% 3-year survival in Phase 2b OST-HER2 metastatic osteosarcoma trialOS Therapies reported interim 3-year survival findings from its Phase 2b OST-HER2 trial in fully resected p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL6TnGBC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816544","title":"OS Therapies Management to Attend H.C. Wainwright Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816544","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816544?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:21","pubTimestamp":1788348065,"startTime":"0","endTime":"0","summary":"OS Therapies management to attend H.C. Wainwright Global Investment ConferenceOS Therapies management to attend investor conferences in New York on Sept. 14-16, Sept. 29, Nov. 16-19, 2026.Business dev","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL2G64gj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX","CFSU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661904722","title":"OS Therapies Launches $75 Million At-The-Market Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2661904722","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661904722?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:17","pubTimestamp":1787347078,"startTime":"0","endTime":"0","summary":"OS Therapies Incorporated ( ($OSTX) ) has shared an announcement. On August 21, 2026, OS Therapies Incorporated entered into an Open Market Sale Ag...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/os-therapies-launches-75-million-at-the-market-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/os-therapies-launches-75-million-at-the-market-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661929033","title":"OS Therapies Launches USD 75 Million At-the-Market Equity Offering Via Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2661929033","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661929033?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:51","pubTimestamp":1787345497,"startTime":"0","endTime":"0","summary":"OS Therapies launches USD 75 million at-the-market equity offering via JefferiesOS Therapies entered an at-the-market equity distribution agreement with Jefferies to sell up to USD 75 million of commo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4x6yPQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661008297","title":"Os Therapies - Enters Open Market Sale Agreement with Jefferies - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2661008297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661008297?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:43","pubTimestamp":1787345006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0GG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660538462","title":"Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and Nicola Mining Inc. Unsponsored ADR (NICM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660538462","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660538462?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:50","pubTimestamp":1787053809,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on OS Therapies Incorporated (OSTX) and Nicola Mining Inc. Unsp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-os-therapies-incorporated-ostx-and-nicola-mining-inc-unsponsored-adr-nicm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-os-therapies-incorporated-ostx-and-nicola-mining-inc-unsponsored-adr-nicm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DIVL","OSTX","HUSIF","BK4141","BK4168","AADR","CVY","APIE","DINT","SAPH","NA","BK4139","ARMH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121249","title":"OS Therapies Net Loss Widens to $19.03 Million in FY26 First Half; Revenue Remains no Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121249","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121249?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:05","pubTimestamp":1786741554,"startTime":"0","endTime":"0","summary":"OS Therapies net loss widens to $19.03 million in FY26 first half; revenue remains no revenueOS Therapies posted a GAAP net loss of USD 19.03 million for the six months ended June 30, 2026, widening f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL8s72q7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659152145","title":"OS Therapies Wins FDA Type C Meeting to Review 2.5-Year Survival Data for OST-HER2 Phase 2b Osteosarcoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659152145","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659152145?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:46","pubTimestamp":1786625170,"startTime":"0","endTime":"0","summary":"OS Therapies wins FDA Type C meeting to review 2.5-year survival data for OST-HER2 Phase 2b osteosarcoma trialOS Therapies secured an FDA Type C statistical methods meeting to review 2.5-year survival","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLBYlt4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659183245","title":"OS Therapies Announces Convertible Note Financing and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2659183245","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659183245?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:19","pubTimestamp":1786569550,"startTime":"0","endTime":"0","summary":"OS Therapies Incorporated ( ($OSTX) ) has provided an update. On August 10, 2026, OS Therapies Incorporated closed the first tranche of a senior se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/os-therapies-announces-convertible-note-financing-and-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/os-therapies-announces-convertible-note-financing-and-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":62,"code":"91000000","status":"200"}]}}